Alcohol abuse and alcoholism: An overview

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 20, 2001, Pages 4-10

  Volpicelli, J R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; DOPAMINE; DOPAMINE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALTREXONE; OPIATE RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ALCOHOLICS ANONYMOUS; ALCOHOLISM; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST CONTROL; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; MALE; MENTAL DISEASE; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSOCIAL ENVIRONMENT; PSYCHOTHERAPY; REVIEW; SEROTONINERGIC NERVE CELL; UNITED STATES;

ALCOHOL-RELATED DISORDERS; ALCOHOLISM; ATTITUDE TO HEALTH; CLINICAL TRIALS; COST SAVINGS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PATIENT COMPLIANCE; PREVALENCE; STEREOTYPING; TREATMENT OUTCOME; UNITED STATES;

EID: 0034809246     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Prevalence and correlates of alcohol use and DSM-IV alcohol dependence in the United States: Results of the National Longitudinal Alcohol Epidemiologic Survey
2. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
3. Prevalence of DSM-IV alcohol abuse and dependence, United States 1992
4. Economic costs of substance abuse, 1995
5. The economic impact of alcohol abuse and alcoholism
6. Mortality and morbidity attributable to use of addictive substances in the United States
7. Matching alcoholism treatments to client heterogeneity: Treatment main effects and matching effects on drinking during treatment
8. Impact of alcoholism treatment on total health care costs: A six-year study
9. Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism
10. Nosology and epidemiology of addictive disorders and their comorbidity
11. Serotonin-altering medications and desire, consumption and effects of alcohol-treatment implications
12. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics
13. Buspirone treatment of anxious alcoholics: A placebo-controlled trial
14. Fluoxetine in depressed alcoholics: A double-blind, placebo-controlled trial
15. Nefazodone treatment of major depression in alcohol-dependent patients: A double-blind, placebo-controlled trial
16. Improving naltrexone response: An intervention for medical practitioners to enhance medication compliance in alcohol dependent patients
17. The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption
18. Endogenous opioid systems and alcohol addiction
19. 2 receptors
20. Endogenous opioids and excessive alcohol consumption
21. Implication of the endogenous opioid system in excessive ethanol consumption
22. Alteration of ethanol self-administration by naltrexone
23. Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey
24. Naltrexone blocks the post-shock increase of ethanol consumption
25. Opiates and alcohol self-administration in animals
26. Endogenous opioids and alcohol dependence: Opioid alkaloids and the propensity to drink alcoholic beverages
27. Uncontrollable events and alcohol drinking
28. Naltrexone in the treatment of alcohol dependence
29. Naltrexone and coping skills therapy for alcohol dependence: A controlled study
30. Naltrexone and alcohol dependence: Role of subject compliance
31. Enhancing motivation for change in problem drinking: A controlled comparison of two therapist styles
32. Sertraline treatment for alcohol dependence: Interactive effects of medication and subtype
33. Alcoholic patients' experience and attitudes on pharmacotherapy for alcoholism